Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q4 EPS of ($0.41), $0.10 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.